These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26527831)

  • 41. Extraocular sebaceous carcinoma in situ: report of three cases and review of the literature.
    Aung PP; Batrani M; Mirzabeigi M; Goldberg LJ
    J Cutan Pathol; 2014 Jul; 41(7):592-6. PubMed ID: 24666211
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sebaceous adenoma arising within an ovarian mature cystic teratoma in Muir-Torre syndrome.
    Smith J; Crowe K; McGaughran J; Robertson T
    Ann Diagn Pathol; 2012 Dec; 16(6):485-8. PubMed ID: 21684182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New facial papules in a 66-year-old woman with bladder cancer.
    Nakrani RN; Ghosh A; Richard Lee CC; Agarwal PK; Apolo AB; Cowen EW
    J Am Acad Dermatol; 2014 Dec; 71(6):1250-5. PubMed ID: 25108634
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Muir-Torre syndrome and Turcot syndrome].
    Velter C; Caussade P; Fricker JP; Cribier B
    Ann Dermatol Venereol; 2017; 144(8-9):525-529. PubMed ID: 28256262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isotretinoin as chemoprophylaxis for cutaneous malignancies in Muir-Torre syndrome: A novel concept.
    Joshi TP; Farr MA; Lewis DJ
    Dermatol Ther; 2022 Jul; 35(7):e15540. PubMed ID: 35477944
    [No Abstract]   [Full Text] [Related]  

  • 46. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.
    Jessup CJ; Redston M; Tilton E; Reimann JD
    Hum Pathol; 2016 Mar; 49():1-9. PubMed ID: 26826402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Case for diagnosis. Verrucous plaque on the pubic region.
    Silva DHM; Gouveia de Oliveira AK; Valente NYS; do Amaral Carneiro Cunha T
    An Bras Dermatol; 2021; 96(1):103-105. PubMed ID: 33288371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cutaneous sebaceous tumours and Lynch syndrome: long-term follow-up of 60 patients.
    Marcoval J; Talavera-Belmonte A; Fornons-Servent R; Bauer-Alonso A; Penín RM; Servitje O
    Clin Exp Dermatol; 2019 Jul; 44(5):506-511. PubMed ID: 30430625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sebaceous gland tumors of the eyelids and conjunctiva in the Muir-Torre syndrome: a clinicopathologic study of five cases and literature review.
    Rishi K; Font RL
    Ophthalmic Plast Reconstr Surg; 2004 Jan; 20(1):31-6. PubMed ID: 14752307
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sebaceous carcinoma of the eyelid in an immunocompromised patient with Muir-Torre syndrome.
    Stockl FA; Dolmetsch AM; Codère F; Burnier MN
    Can J Ophthalmol; 1995 Oct; 30(6):324-6. PubMed ID: 8574982
    [No Abstract]   [Full Text] [Related]  

  • 51. Muir-Torre syndrome: clinical features and molecular genetic analysis.
    Esche C; Kruse R; Lamberti C; Friedl W; Propping P; Lehmann P; Ruzicka T
    Br J Dermatol; 1997 Jun; 136(6):913-7. PubMed ID: 9217825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Considerations on the performance of immunohistochemistry for mismatch repair gene proteins in cases of sebaceous neoplasms and keratoacanthomas with reference to Muir-Torre syndrome.
    Fernandez-Flores A
    Am J Dermatopathol; 2012 Jun; 34(4):416-22. PubMed ID: 22123265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extraocular well-differentiated sebaceous tumors with overlying cutaneous horns: four tumors in three patients.
    Jhuang JY; Liao SL; Tsai JH; Chang HC; Kuo KT; Liau JY
    J Cutan Pathol; 2014 Aug; 41(8):650-6. PubMed ID: 24548110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Muir-Torre syndrome: a case report.
    Bisceglia M; Zenarola P
    Tumori; 1991 Jun; 77(3):277-81. PubMed ID: 1862560
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Muir-Torre syndrome.
    Ponti G; Ponz de Leon M
    Lancet Oncol; 2005 Dec; 6(12):980-7. PubMed ID: 16321766
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Muir-Torre syndrome associated with Waldenstrom's macroglobulinemia].
    Velter C; Bourlond F; Wettle C; Lioure B; Lipsker D; Maugard C; Cribier B
    Ann Dermatol Venereol; 2016 Dec; 143(12):825-830. PubMed ID: 27771121
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Muir-Torre syndrome: rare association with duodenal carcinoma].
    Bacha D; Deschamps L; Sauvanet A; Couvelard A
    Ann Pathol; 2009 Dec; 29(6):495-8. PubMed ID: 20005439
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adnexal tumours of the skin as markers of cancer-prone syndromes.
    Kanitakis J
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):379-87. PubMed ID: 19744258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sebaceous Neoplasms With Rippled, Labyrinthine/Sinusoidal, Petaloid, and Carcinoid-Like Patterns: A Study of 57 Cases Validating Their Occurrence as a Morphological Spectrum and Showing No Significant Association With Muir-Torre Syndrome or DNA Mismatch Repair Protein Deficiency.
    Wiedemeyer K; Kyrpychova L; Işikci ÖT; Spagnolo DV; Kutzner H; Rütten A; Fernandez-Figueras MT; Denisjuk N; Suster S; Pavlovsky M; Petersson F; Michal M; Lee J; Kerl K; Kazakov DV
    Am J Dermatopathol; 2018 Jul; 40(7):479-485. PubMed ID: 29924747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Muir-Torre syndrome-is it really a new syndrome?
    Grzybowski A; Jabłońska S
    Am J Dermatopathol; 2009 Dec; 31(8):799-802. PubMed ID: 19955878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.